Acadia Pharmaceuticals Inc. (ACAD) on GreekSoup https://greeksoup.ai/stocks/us/acad/ Every dated entry in the public record on Acadia Pharmaceuticals Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Acadia Pharmaceuticals Inc.: short interest 8,275,918 shares at the 30 September 2026 settlement, 2.93 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-09-30:448136fc19Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/acad/filings/us:ACAD:filing:2026-09-24:85b7c0f174Thu, 24 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: short interest 9,666,972 shares at the 15 September 2026 settlement, 7.22 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-09-15:d2ac4e6bc9Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/acad/filings/us:ACAD:filing:2026-09-11:1a7cdfa1bfFri, 11 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: short interest 9,739,720 shares at the 31 August 2026 settlement, 6.93 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-08-31:c392237c18Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: short interest 9,478,912 shares at the 14 August 2026 settlement, 4.54 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-08-14:77f2706385Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Schedule 13G filed by STATE STREET CORPORATION, 5.3% of the classhttps://greeksoup.ai/stocks/us/acad/holders/us:ACAD:schedule-13:2026-08-07:b52ff79512Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 5,000 shares at $29.00 on 6 August 2026, $145,000https://greeksoup.ai/stocks/us/acad/insiders/us:ACAD:insider:2026-08-07:0bafb79af5Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 9,292 shares at $29.34 on 6 August 2026, $272,604https://greeksoup.ai/stocks/us/acad/insiders/us:ACAD:insider:2026-08-07:33bc6d6bd9Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 5,849 shares at $29.00 on 5 August 2026, $169,638https://greeksoup.ai/stocks/us/acad/insiders/us:ACAD:insider:2026-08-07:1220a1a140Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc. Q2 FY2026 results: revenue $308 million, net income $32 millionhttps://greeksoup.ai/stocks/us/acad/results/fy2026-q2/us:ACAD:result:2026-08-05:098a2a30c1Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/acad/filings/us:ACAD:filing:2026-08-05:16e5b8f400Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Form 144, Schneyer Mark C. plans to sell 5,849 shares worth $158,800 around 5 August 2026https://greeksoup.ai/stocks/us/acad/planned-sales/us:ACAD:planned-sale:2026-08-05:84433ffd35Wed, 05 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/acad/filings/us:ACAD:filing:2026-08-04:315ee3dfafTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Thompson Elizabeth H.Z. (EVP, Head of Research & Dev) sold 16,508 shares at $26.13 on 30 July 2026, $431,354https://greeksoup.ai/stocks/us/acad/insiders/us:ACAD:insider:2026-07-31:89fe49b8c3Fri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: Thompson Elizabeth H.Z. (EVP, Head of Research & Dev) sold 50 shares at $26.17 on 30 July 2026, $1,308https://greeksoup.ai/stocks/us/acad/insiders/us:ACAD:insider:2026-07-31:24d802f739Fri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: short interest 10,812,093 shares at the 31 July 2026 settlement, 7.96 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-07-31:f769e6b06eFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Acadia Pharmaceuticals Inc.: short interest 11,029,444 shares at the 15 July 2026 settlement, 7.61 days to coverhttps://greeksoup.ai/stocks/us/acad/short-interest/us:ACAD:short-interest:2026-07-15:b94c6301d7Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>